K Matsui

Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer.

N Masuda, K Matsui, S Negoro et al. · Journal of Clinical Oncology · 1998 · 101 citations

Medicine, Oncology, Pharmacology +15

Development of 10 Wh class lithium secondary cells in the ‘New Sunshine Program’

J. Aragane, K Matsui, H. Andoh et al. · Journal of Power Sources · 1997 · 58 citations

Engineering, Materials Engineering, Materials Science +14

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

K Matsui, N Masuda, M. Fukuoka et al. · British Journal of Cancer · 1998 · 55 citations · Full text

Medicine, Oncology, Pharmacology +12

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

M. Fukuoka, N Masuda, Shunichi Negoro et al. · British Journal of Cancer · 1997 · 51 citations · Full text

Medicine, Oncology, Pharmacology +14

Disruption of the EGFR E884–R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity

Zhe Tang, Shan Jiang, Ruikai Du et al. · Oncogene · 2008 · 18 citations · Full text

Life Sciences, Genetics, Molecular Biology +9